Back to Search Start Over

A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity

Authors :
Warren J. Leonard
Nima Rezaei
Kathryn Payne
Isabelle Meyts
Laurent Abel
Cindy S. Ma
Marianne Leruez-Ville
Janet Chou
Alain Hovnanian
Jian-Xin Lin
Simon J. Pelham
Danielle T. Avery
Matthieu Bouaziz
Bethany Pillay
Tanwir Habib
Anne Puel
Sevgi Keles
Juan Li
Isabelle Pellier
Jamel El-Benna
Bernhard Fleckenstein
Ahmet Ozen
Vivien Béziat
Ingrid Müller-Fleckenstein
Damien Chaussabel
Samaneh Zoghi
Yi Wang
Paul Gray
Matthias Titeux
Yoann Zerbib
Talal A. Chatila
Marie-Alexandra Alyanakian
Capucine Picard
Orli Wargon
Ayper Somer
Marie-Olivia Chandesris
Thibaut Leclercq
Ibtihal Benhsaien
Aziz Belkadi
Jean-Laurent Casanova
Romain Lévy
Peng Li
Geetha Rao
Ai Ing Lim
James P. Di Santo
Nico Marr
Sylvie Fraitag
Frédégonde About
Elissa K. Deenick
Bertrand Boisson
Jacinta Bustamante
Mélanie Migaud
Bodo Grimbacher
Aziz Bousfiha
Fatima Ailal
Safa Baris
Antoine Guérin
Stuart G. Tangye
Romain Guery
Ning Du
Vimel Rattina
Imagine - Institut des maladies génétiques (IMAGINE - U1163)
Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Rockefeller University [New York]
National Institutes of Health [Bethesda] (NIH)
Garvan Institute of Medical Research [Darlinghurst, Australia]
University of New South Wales [Sydney] (UNSW)
CHU Ibn Rochd [Casablanca]
Université Hassan II [Casablanca] (UH2MC)
Service d'Immuno-Hémato-Oncologie Pédiatrique
Centre Hospitalier Universitaire d'Angers (CHU Angers)
PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)
Shahid Beheshti University of Medical Sciences [Tehran] (SBUMS)
Shahid Beheshti University
Universal Scientific Education and Research Network (USERN)
Marmara University [Kadıköy - İstanbul]
Necmettin Erbakan University [Konya, Turquie]
Immunité Innée
Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Harvard Medical School [Boston] (HMS)
Boston Children's Hospital
Centre d'infectiologie Necker-Pasteur [CHU Necker]
CHU Necker - Enfants Malades [AP-HP]
Sidra Medicine
Centre de recherche sur l'Inflammation (CRI (UMR_S_1149 / ERL_8252 / U1149))
Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7)
Freiburg University Medical Center
Sydney children's hospital
Centre de Référence Déficits Immunitaires Héréditaires (CEREDIH)
Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Necker - Enfants Malades [AP-HP]
Friedrich-Alexander Universität Erlangen-Nürnberg (FAU)
Genetic skin diseases : from disease mechanism to therapies (Equipe Inserm U1163)
Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Service de pathologie [CHU Necker]
Service d'immuno-hématologie pédiatrique [CHU Necker]
Laboratoire de Virologie [CHU Necker]
Université Paris Descartes - Paris 5 (UPD5)
Centre d'étude des Déficits Immunitaires
University Hospitals Leuven [Leuven]
Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven)
Istanbul University
Research Center for Immunodeficiencies [Tehran, Iran]
Tehran University of Medical Sciences (TUMS)
University of New South Wales [Canberra Campus] (UNSW)
Howard Hughes Medical Institute [New York]
New York University School of Medicine
NYU System (NYU)-NYU System (NYU)-Rockefeller University [New York]-Columbia University Irving Medical Center (CUIMC)
This work was supported by grants from INSERM, Paris Descartes University, Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID), the Jeffrey Modell Foundation Translational Research Program, the French National Research Agency (ANR
grant nos. GENCMCD-ANR-11-BSV3–005-01, HGDIFD-ANR-14-CE15-0006-01, NKIR-ANR-13-PDOC-0025-01, and EURO-CMC-ANR-14-RARE-0005-02), and grants awarded under the 'Investissement d’avenir' program (grant no. ANR-10-IAHU-01), the National Institute of Allergy and Infectious Diseases of the NIH (grant nos. U01AI109697 and R01AI127564), the Rockefeller University, the Howard Hughes Medical Institute, the St. Giles Foundation, the Institut Pasteur, and FP7, under grant agreements 305578 (PathCO) and 317057 (HOMIN). We thank the Centre de Recherche Translationnelle (Institut Pasteur) for technical assistance. V.B. is supported by the ANR (grant no. NKIR-ANR-13-PDOC-0025-01). R.L. is supported by the INSERM Ph.D. program (Poste d’Accueil INSERM), a Fulbright grant (Franco-American commission), and a Philippe Foundation scholarship. Y.Z. received the 'médaille d’or du Centre Hospitalier Universitaire d’Amiens.' Y.W. is supported by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS
grant no. 13318). F. About holds a fellowship from Fondation pour la Recherche Médicale (FRM
grant no. FDM20140630671). A.G. is supported by an IFNGPHOX grant (no. ANR13-ISV3-0001-01) from ANR. B.G. was funded by BMBF (German Federal Ministry of Education and Research) grants 01E01303 and 01ZX1306F. I.M. is supported by a klinische onderzoeks-en opleidingsraad (clinical research council) grant from UZ Leuven, a klinisch onderzoeksfonds (clinical research fund) grant from KU Leuven, and an International Mobility Grant from Fonds voor Wetenschappelijk Onderzoek (fund for scientific research) Vlaanderen. C.S.M., E.K.D., and S.G.T. are supported by grants and fellowships from the National Health and Medical Research Council of Australia. C.S.M., P.G., E.K.D., and S.G.T. are members of CIRCA (Clinical Immunogenomics Research Consortia Australia), which is funded by the Office of Health and Medical Research of the NSW Government, the Jeffrey Modell Foundation, and the John Cook Brown Foundation. A.I.L. is a scholar of the Pasteur-Paris University International Ph.D. program and is supported by a Ph.D. International Training Network grant from the European Union’s Seventh Framework Program under grant agreement no. 317057 (HOMIN). T.A.C. was supported by a grant from the National Institute of Allergy and Infectious Diseases of the NIH (5R01AI065617). S.K. was supported by a grant from the Scientific and Technological Research Council of Turkey (1059B191300622). J.-X.L., P.L., N.D., and W.J.L. were supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH. A.P. was supported by an AP-HP interface contract.
We thank the patients and their families for participating in this study. We thank J. E. Darnell and C. Mertens for advice and for providing reagents. We thank the members of the laboratory, especially F. Jabot-Hanin and V. Pedergnana, for their valuable input on linkage analysis
L. Amar, Y. Nemirovskaya, D. Papandrea, E. Anderson, M. Woollett, C. Desvallées, C. Patissier, and M. Corrias for administrative assistance
E. Jouanguy and Y. Itan for helpful discussions
S. Boucherit for clinical data collection
S. Jacques and the Cochin genomics platform for microarray experiments
and N. Goudin and R. Desveaux of the Necker Institute Imaging Facility.
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Garvan Institute of medical research
Immunité Innée - Innate Immunity
Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Institut Pasteur [Paris] (IP)-CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Sidra Medicine [Doha, Qatar]
Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Universitäts Klinikum Freiburg = University Medical Center Freiburg (Uniklinik)
Sydney Children's hospital
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Howard Hughes Medical Institute [New York] (HHMI)
Howard Hughes Medical Institute (HHMI)-New York University School of Medicine
Institut Pasteur [Paris]-CHU Necker - Enfants Malades [AP-HP]
Beziat, Vivien
Li, Juan
Lin, Jian-Xin
Ma, Cindy S.
Li, Peng
Bousfiha, Aziz
Pellier, Isabelle
Zoghi, Samaneh
Baris, Safa
Keles, Sevgi
Gray, Paul
Du, Ning
Wang, Yi
Zerbib, Yoann
Levy, Romain
Leclercq, Thibaut
About, Fredegonde
Lim, Ai Ing
Rao, Geetha
Payne, Kathryn
Pelham, Simon J.
Avery, Danielle T.
Deenick, Elissa K.
Pillay, Bethany
Chou, Janet
Guery, Romain
Belkadi, Aziz
Guerin, Antoine
Migaud, Melanie
Rattina, Vimel
Ailal, Fatima
Benhsaien, Ibtihal
Bouaziz, Matthieu
Habib, Tanwir
Chaussabel, Damien
Marr, Nico
El-Benna, Jamel
Grimbacher, Bodo
Wargon, Orli
Bustamante, Jacinta
Boisson, Bertrand
Mueller-Fleckenstein, Ingrid
Fleckenstein, Bernhard
Chandesris, Marie-Olivia
Titeux, Matthias
Fraitag, Sylvie
Alyanakian, Marie-Alexandra
Leruez-Ville, Marianne
Picard, Capucine
Meyts, Isabelle
Di Santo, James P.
Hovnanian, Alain
Somer, Ayper
Ozen, Ahmet
Rezaei, Nima
Chatila, Talal A.
Abel, Laurent
Leonard, Warren J.
Tangye, Stuart G.
Puel, Anne
Casanova, Jean-Laurent
Source :
Science Immunology, Science Immunology, American Association for the Advancement of Science, 2018, 3 (24), pp.eaat4956. ⟨10.1126/sciimmunol.aat4956⟩, Science Immunology, 2018, 3 (24), pp.eaat4956. ⟨10.1126/sciimmunol.aat4956⟩
Publication Year :
2018
Publisher :
American Association for the Advancement of Science (AAAS), 2018.

Abstract

Comment in :Who regulates whom: ZNF341 is an additional player in the STAT3/TH17 song. [Sci Immunol. 2018]; International audience; Heterozygosity for human signal transducer and activator of transcription 3 (STAT3) dominant-negative (DN) mutations underlies an autosomal dominant form of hyper-immunoglobulin E syndrome (HIES). We describe patients with an autosomal recessive form of HIES due to loss-of-function mutations of a previously uncharacterized gene, ZNF341 ZNF341 is a transcription factor that resides in the nucleus, where it binds a specific DNA motif present in various genes, including the STAT3 promoter. The patients' cells have low basal levels of STAT3 mRNA and protein. The autoinduction of STAT3 production, activation, and function by STAT3-activating cytokines is strongly impaired. Like patients with STAT3 DN mutations, ZNF341-deficient patients lack T helper 17 (TH17) cells, have an excess of TH2 cells, and have low memory B cells due to the tight dependence of STAT3 activity on ZNF341 in lymphocytes. Their milder extra-hematopoietic manifestations and stronger inflammatory responses reflect the lower ZNF341 dependence of STAT3 activity in other cell types. Human ZNF341 is essential for the STAT3 transcription-dependent autoinduction and sustained activity of STAT3.

Subjects

Subjects :
0301 basic medicine
INBORN-ERRORS
Immunoglobulin E
MESH: STAT3 Transcription Factor/immunology
Loss of heterozygosity
PRECISION MEDICINE
Transcription (biology)
OF-FUNCTION MUTATIONS
STAT3
MESH: Transcription Factors/metabolism
CELL-DIFFERENTIATION
MESH: Th2 Cells/metabolism
MESH: Immunoglobulin E/immunology
MESH: Middle Aged
MESH: Gene Expression Regulation/immunology
Cell Differentiation
General Medicine
MESH: RNA, Messenger/metabolism
MESH: Immunoglobulin E/blood
MESH: Zinc Fingers/genetics
READ ALIGNMENT
MESH: Transcription, Genetic/immunology
MESH: Cell Nucleus/metabolism
MESH: Young Adult
[SDV.IMM]Life Sciences [q-bio]/Immunology
SIGNAL TRANSDUCER
Job Syndrome
MESH: Homozygote
STAT3 Transcription Factor
Cell type
MESH: Lymphocyte Count
MESH: Pedigree
MESH: STAT3 Transcription Factor/genetics
Immunology
Biology
Article
MESH: Job Syndrome/immunology
MESH: Genes, Recessive/genetics
DIFFERENTIAL EXPRESSION
MESH: Genes, Recessive/immunology
MESH: Job Syndrome/blood
MESH: Transcription Factors/genetics
03 medical and health sciences
MESH: Whole Exome Sequencing
MESH: Exons/genetics
Humans
Transcription factor
Gene
MESH: Adolescent
MESH: Consanguinity
MESH: Humans
CLINICAL-FEATURES
MESH: Th17 Cells/metabolism
MESH: Th17 Cells/immunology
MESH: Cytokines/immunology
MESH: Adult
MESH: Loss of Function Mutation
MESH: Job Syndrome/genetics
MESH: Cell Differentiation/genetics
Molecular biology
MESH: Male
MESH: Th2 Cells/immunology
IL-21 RECEPTOR
030104 developmental biology
Gene Expression Regulation
MESH: STAT3 Transcription Factor/metabolism
MESH: Promoter Regions, Genetic/genetics
MESH: Cell Differentiation/immunology
T-CELLS
STAT protein
biology.protein
Th17 Cells
MESH: Transcription Factors/immunology
MESH: Cytokines/metabolism
MESH: Female

Details

ISSN :
24709468
Volume :
3
Database :
OpenAIRE
Journal :
Science Immunology
Accession number :
edsair.doi.dedup.....a014e03bf19bbdfb4eb205a53e190a3a
Full Text :
https://doi.org/10.1126/sciimmunol.aat4956